Processing

Please wait...

Settings

Settings

Goto Application

1. IN3879/DELNP/2007 - "IDENTIFICATION OF A JAK2 MUTATION IN POLYCYTHEMIA VERA"

Office
India
Application Number 3879/DELNP/2007
Application Date 23.05.2007
Publication Number 3879/DELNP/2007
Publication Date 31.08.2007
Grant Number 301163
Grant Date 19.09.2018
Publication Kind B
IPC
C12N 9/12
CCHEMISTRY; METALLURGY
12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
9Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes
10Transferases (2.)
12transferring phosphorus containing groups, e.g. kinases (2.7)
Applicants ASSISTANCE PUBLIQUE-HOPITAUX DE PARIS
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM)
INSTITUT GUSTAVE-ROUSSY
UNIVERSITE DE VERSAILLES-ST QUENTIN EN YVELINES
UNIVERSITE PARIS-SUD
Inventors VAINCHENKER, WILLIAM
UGO, VALERIE
JAMES, CHLOE
LE COUEDIC, JEAN-PIERRE
CASADEVALL, NICOLE
Priority Data 0411480 27.10.2004 FR
Title
(EN) "IDENTIFICATION OF A JAK2 MUTATION IN POLYCYTHEMIA VERA"
Abstract
(EN) The invention relates to variant V617F of protein tyrosine Kinase JAK2, said variant being responsible for Polycythemia Vera. The invention also relates to a method for the preliminary diagnosis of erythrocytosis and thrombocytosis, thereby enabling same to be related to myeloproliferative syndromes or the detection of variant JAK2 V617F in said myeloproliferative syndromes, such that they can be reclassified in a new nosological group, and to the identification of specific inhibitors and siRNA.